Diabetic Neuropathy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

The global diabetic neuropathy market is dominated by a small number of foreign and local producers with small market shares. As a result, the competitive environment is semi-consolidated. The competition among them is fierce, with the majority of them devoting time and resources to the creation of increasingly effective neuropathy medications.

Changing lifestyles, which have generally resulted in unhealthy food habits and patterns, are driving the worldwide diabetic neuropathy market. According to the World Health Organization, 422 people were diagnosed with diabetes in 2014. Other market growth drivers include the approval of innovative medications to treat neuropathic pain and favourable reimbursement policies.

Drugs used to treat neuropathic pain, on the other hand, have had mixed results in terms of pain alleviation. This, in combination with incorrect diagnosis or therapy selection, side effects, and the rising cost of diabetic neuropathy treatment medications, is creating a challenge to the diabetic neuropathy business.

The most common illnesses in the worldwide diabetic neuropathy market are peripheral neuropathy, autonomic neuropathy, proximal neuropathy, and focal neuropathy. Peripheral neuropathy, for example, currently accounts for over half of the market. It is expected to grow its market share slightly in the near future, outpacing all other segments in terms of growth rate.

When it comes to market share in the worldwide diabetic neuropathy market, proximal neuropathy trails behind peripheral neuropathy. This is due to the fact that proximal diabetic neuropathy is the most frequent type 2 diabetes condition. The segment was worth US$885.6 million in 2016 and is expected to grow at a CAGR of 5.4 percent from 2017 to 2025, reaching US$1.405 million.

The worldwide diabetic neuropathy market is expected to generate substantial revenues due to changing lifestyles and increased adoption of poor eating practises. Medications used to treat neuropathic pain, on the other hand, have only had limited success in terms of providing pain relief.